Correlations between clinical motor scores and CMAP in patients with type 2 spinal muscular amyotrophy treated with nusinersen - 03/01/24
, R. Barrois a, I. Desguerre a, E. Deladrière a, V. Leloup-Germa a, C. Barnerias a, C. Gitiaux a, bAbstract |
Background |
Spinal muscular atrophy (SMA) is a neuromuscular disorder characterized by the degeneration of the anterior horn cells of the spinal cord. Nusinersen for the treatment of SMA has been covered by public healthcare in France since May 2017.
Objective |
Our aim was to investigate whether there is a correlation between clinical and compound motor action potential (CMAP) measurements in SMA patients treated with nusinersen after 3 years’ follow-up.
Method |
Motor skills were evaluated regularly between M0 and M36 using the Motor Function Measure (MFM) score. CMAP measurements were collected regularly between M0 and M22.
Results |
Data for 10 patients with SMA type 2 were collected and divided into two age groups (< 5 years and > 5 years). Motor function improved, but not significantly, regarding distal motor skills (D3) in both groups, and in axial and proximal motor function (D2) in the younger group. CMAP measurements improved in all patients. CMAP increased significantly for the median nerve, and this improvement correlated significantly with global MFM and with axial and proximal tone (D2).
Conclusion |
Our study shows gain in distal motor function with nusinersen, especially in younger patients with SMA type 2. These results encourage the screening of SMA patients and treatment as early as possible. CMAP measurements of the median nerve show clear improvement in patients treated with nusinersen and could be performed as routine follow-up.
Le texte complet de cet article est disponible en PDF.Keywords : Spinal muscular atrophy type 2, Nusinersen, Motor function measure (MFM), Electroneuromyography, Compound motor action potential (CMAP)
Plan
Vol 31 - N° 1
P. 26-31 - janvier 2024 Retour au numéro
Article précédent
- Identification of factors associated with the management of childhood obesity: Results from a French pediatric cohort study
- Ariane Thevenard-Berger, Marie Di Patrizio, Carole Legagneur, Arnaud Wiedemann-Fode, Emeline Renard
- Transition care to adolescent hepatology in a tertiary center for rare adult–child liver disease
- Nolwenn Laborde, Karl Barange, Chloé Girard, Clothilde Marbach, Christophe Bureau, Pierre Broué
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?